Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA states Ocugen’s dry eye drug brimonidine tartrate needs to divulge results to avoid a fine,

FDA warned Ocugen that it could face a $10000 fine unless it turns over results from a clinical trial for dry eye drug, brimonidine tartrate, …, FDA warned Ocugen that it could face a $10000 fine unless it turns over results from a clinical trial for dry eye drug, brimonidine tartrate, …, Read More

Scroll to Top